Law, Matthew

. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., et al. (2011) · The Journal of Infectious Diseases

HIV Research and TreatmentHIV-related health complications and treatments

Cited by 1,106

Plant sterol and stanol margarines and health

Law, M. (2000) · BMJ

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 729

Adjuvant psychological therapy for patients with cancer: a prospective randomised trial.

Greer, S., Moorey, S., Baruch, J. D., Watson, M., Robertson, B. M., Mason, A., Rowden, L., Law, M. G., & Bliss, J. M. (1992) · BMJ

Cancer survivorship and carePsychotherapy Techniques and Applications

Cited by 496

Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

Friis-Møller, N., Thiébaut, R., Reiss, P., Weber, R., D'Arminio Monforte, A., De Wit, S., El-Sadr, W., Fontas, E., Worm, S., Kirk, O., et al. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation

HIV-related health complications and treatmentsLipoproteins and Cardiovascular Health

Cited by 384

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, J. M., Emery, S., Kelleher, A. D., Law, M., Chen, J., Hazuda, D. J., Nguyen, B.-Y. T., Teppler, H., & Cooper, D. A. (2007) · AIDS

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 187

Factors associated with mortality in a cohort of Australian prisoners

Kariminia, A., Law, M. G., Butler, T. G., Corben, S. P., Levy, M. H., Kaldor, J. M., & Grant, L. (2007) · European Journal of Epidemiology

Criminal Justice and Corrections AnalysisCriminal Justice and Penology

Cited by 119

The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study.

Bradshaw, C. S., Walker, S. M., Vodstrcil, L. A., Bilardi, J. E., Law, M., Hocking, J. S., Fethers, K. A., Fehler, G., Petersen, S., Tabrizi, S. N., et al. (2014) · Journal of Infectious Diseases

Reproductive tract infections researchGut microbiota and health

Cited by 82

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial

Matthews, G., Jacoby, S., Borok, M., Eriobu, N., Kaplan, R., Kumarasamy, N., Bennet, J. A., Avihingsanon, A., Chetchotisakd, P., Wagner Cardoso, S., et al. (2024) · The Lancet HIV

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 31

The per-protocol effect of immediate versus deferred antiretroviral therapy initiation

Lodi, S., Sharma, S., Lundgren, J. D., Phillips, A. N., Cole, S. R., Logan, R., Agan, B. K., Babiker, A., Klinker, H., Chu, H., et al. (2016) · AIDS

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 27